Understanding OUR Cytokine-Based Immunotherapy Candidates Our motivation extends to advancing a robust portfolio of programs targeted at increasing the horizons of cytokine-based immunotherapy, especially for cancers where cure selections remain limited. Utilize the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Take a look at https://financefeeds.com/israel-moves-forward-with-cbdc-plans/